Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to assess HBV immunity and institute policy regarding the Hepatitis B vaccination practices in the IDF among a cohort that was vaccinated during infancy.


Clinical Trial Description

The study population will consist of both males and females who were born after January 1st 1992, who are in medical training at the Medical Corps Training Base. Demographic information will be obtained through a questionnaire given to the soldiers in the study , as well as the IDF computerized personnel information database.

This study is designed to determine HBV vaccination policy among new HCWs in the IDF, who were vaccinated during infancy. This population was recruited to the IDF since the second half of 2010. Therefore, it is necessary to conduct this study on new HCWs that will be receiving the routine HBV vaccination and that will be at risk for HBV infection in the future due to their occupation in the army (HCWs, etc). ;


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01590381
Study type Observational
Source Medical Corps, Israel Defense Force
Contact Michael Hartal, MD
Phone +972-3-7374137
Email Mhuerta2@gmail.com
Status Recruiting
Phase N/A
Start date December 2011
Completion date April 2013

See also
  Status Clinical Trial Phase
Completed NCT03316807 - Immunogenicity of Hepatitis B Vaccination in HIV-infected Adults Phase 4
Completed NCT02991599 - Immunogenicity of Hepatitis B Vaccination in Methadone Maintenance Treatment Patients Phase 4
Completed NCT02901951 - Long-term Persistence of Immunity to Hepatitis B in Adults Vaccinated With GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine (HBV), Engerix-B Phase 4
Not yet recruiting NCT03962816 - Immunogenicity and Persistence of Hepatitis B Vaccination in Methadone Maintenance Treatment Patients Phase 4
Not yet recruiting NCT03962881 - Research on Optimal Immunization Strategy of Hepatitis B Vaccine in Chronic Kidney Disease Population Phase 4
Not yet recruiting NCT03962803 - Immunogenicity and Persistence of Hepatitis B Vaccination in HIV-Infected Patients Phase 4
Completed NCT02432430 - Comparison of Immunization Quality Improvement Dissemination Study N/A
Not yet recruiting NCT05099757 - The Immunogenicity and Persistence of Booster Dose With Hepatitis B Vaccine in College Students Phase 4
Completed NCT02963714 - Immunogenicity of Hepatitis B Vaccination in Hemodialysis Patients Phase 4
Completed NCT00519649 - Long-term Persistence of Immunity Against Hepatitis B in 7-8 Years Old Children After Hepatitis B Vaccination. Phase 4